BioSpace News Archive

Amniotic Membrane Market: Companies Innovate in Stem Cell-induced hAM for Cardiac Tissue Regeneration

Chronic burn wounds lead to trauma amongst patients. What adds to the patient’s difficulty is the risk of infection, sepsis, joint problems, and scarring during the management of third-degree burns.

October 9, 2020
·
5 min read
Drug Development

Italfarmaco Receives FDA Rare Pediatric Disease Designation for Givinostat in Duchenne Muscular Dystrophy, Announces Completed Enrollment in EPIDYS Phase 3 Trial

The Italfarmaco Group provided an update on the development of Givinostat, its proprietary histone deacetylase inhibitor, in boys with Duchenne Muscular Dystrophy.

October 9, 2020
·
4 min read
U.S. Wound Care Centers Market | Exclusive Report on the Current Scenario of the Market

Wounds are defined as any external breakage in the continuity of the skin due to trauma or internal inflammation.

October 9, 2020
·
3 min read
Varicose Vein Treatment Market: Increase in Awareness and Rise in Prevalence of Varicose Vein is a major key driver

Endovenous Cyanoacrylate Glue and Polidocanol Injectable Foam Gain Popularity as Minimally-invasive Treatment Options

October 9, 2020
·
5 min read
Radioimmunoassay Market: Rise in prevalence of cancer and other infectious diseases is expected to lead to growth of the market

Radioimmunoassay (RIA) is an in vitro assay for measuring antibody levels by introducing a radiolabeled antigen and determining the subsequent radioactivity of the antibody component.

October 9, 2020
·
5 min read
Cerebrospinal Fluid (CSF) Testing Market: Neurological Segment to Dominate the Market

Cerebrospinal fluid is a clear, colorless liquid that surrounds the spinal cord and provides a cushion and essential nutrients to the central nervous system.

October 9, 2020
·
5 min read
Grifols’ anti-SARS-CoV-2 hyperimmune globulin begins clinical trial in patients with COVID-19

The trial, part of a collaboration with U.S. government agencies including BARDA, the FDA and the NIH, will evaluate the safety, efficacy and tolerability of the anti-SARS-CoV-2 hyperimmune globulin that, if proven safe and effective, could be a potential treatment for COVID-19

October 9, 2020
·
7 min read
Superabsorbent Dressings Market is driven by increasing number of patients suffer from wounds that fail to heal

Superabsorbent dressings are designed to absorb and retain exudate. Superabsorbent dressings are promoted for use on moderate to highly exudate wounds to absorb and retain fluid, thus reducing the risk of leakage and minimizing the risk of maceration.

October 9, 2020
·
4 min read
Renal Colic Treatment Market: Growing Incidence of Urolithiasis to drive the market

Renal colic is a symptom of urinary stones. Renal colic is pain that occurs due to a stone in the urinary tract.

October 9, 2020
·
5 min read
Drug Development

Exelixis to Present the Preclinical Profile and Initial Clinical Pharmacokinetics of XL092, Its Next-Generation Oral Tyrosine Kinase Inhibitor

Exelixis, Inc. announced new data that support the ongoing clinical development of XL092, the company’s next-generation oral tyrosine kinase inhibitor that targets VEGF receptors, MET, AXL, MER, and other kinases implicated in cancer’s growth and spread.

October 9, 2020
·
7 min read